- Filed
- Jun 23, 2026 4:10 PM ET
- Period of report
- Mar 13, 2026
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 13, 2026 | 42.9M sh |
| Current Assets | 2026 · Jan 31, 2026 | $6.34M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $22.46M |
| Stock Issued | Q3 2026 · Jan 31, 2026 | 17.58K sh |
| Shares Diluted restated | Q3 2026 · Jan 31, 2026 | 55.56M sh |
| Shares Diluted restated | Q3 2026 · Jan 31, 2026 | 42.61M sh |
| Stock Repurchased | Q3 2026 · Jan 31, 2026 | $12.77M |
| Capex | Q3 2026 · Jan 31, 2026 | $9.44K |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −$32.11M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $11.32M |
| Cash And Equivalents | Q3 2026 · Aug 5, 2025 | $208.3M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $364.88M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $484.89M |
| Stockholders Equity | Q3 2026 · Jun 7, 2025 | $7.81M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $8.57M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $71.89M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $436.77M |
| Total Assets | Q3 2026 · Jan 31, 2025 | $8.34M |
| Eps Diluted restated | Q3 2026 · Jan 31, 2026 | −$1.92 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2026 | $4.02 |
| Eps Basic restated | Q3 2026 · Jan 31, 2026 | −$1.92 |
| Eps Basic restated | Q3 2026 · Jan 31, 2026 | $4.03 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $6M |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $34.6M |
| Net Income | Q3 2026 · Jan 31, 2026 | −$106.57M |
| Net Income | Q3 2026 · Jan 31, 2026 | $171.22M |
| Net Income | Q3 2026 · Jan 31, 2026 | $171.22M |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$164.31M |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$80.14M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $1.76M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $5.23M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $5.57M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $13.83M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $5.15M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $13.82M |
| Revenue | Q3 2026 · Jan 31, 2026 | $7.33M |
| Revenue | Q3 2026 · Jan 31, 2026 | $19.06M |
| Revenue | Q3 2026 · Jan 31, 2025 | $6.91M |
| Revenue | Q3 2026 · Jan 31, 2025 | $21.31M |